343
Views
41
CrossRef citations to date
0
Altmetric
Review

Immunomodulatory therapy for sepsis: an update

, &
Pages 1013-1033 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Peng Lu, Lei Zhang, Ting Liu, Jing-Jing Fan, Xu Luo & Yi-Tang Zhu. (2022) MiR-494-mediated Effects on the NF-κB Signaling Pathway Regulate Lipopolysaccharide-Induced Acute Kidney Injury in Mice. Immunological Investigations 51:5, pages 1372-1384.
Read now
Jonathan S Boomer, Jonathan M Green & Richard S Hotchkiss. (2014) The changing immune system in sepsis. Virulence 5:1, pages 45-56.
Read now
Eirini Christaki. (2013) Personalized medicine in sepsis: the coming of age. Expert Review of Anti-infective Therapy 11:7, pages 645-647.
Read now
James D. Faix. (2013) Biomarkers of sepsis. Critical Reviews in Clinical Laboratory Sciences 50:1, pages 23-36.
Read now

Articles from other publishers (36)

Yan Meng, Kai-wen Kong, Yong-qing Chang, Xiao-ming Deng & Tao Yang. (2023) Histone methyltransferase SETD2 inhibits M1 macrophage polarization and glycolysis by suppressing HIF-1α in sepsis-induced acute lung injury. Medical Microbiology and Immunology 212:5, pages 369-379.
Crossref
Juveria Usmani, Mohd Wasim, Mohd Nazam Ansari, Mohammed Jaseem Hassan, Manju Sharma & Razi Ahmad. (2023) Potential therapeutic effect of Carica papaya leaves extract on immune response, biochemical and hematological mechanisms on cecal ligation and puncture model of sepsis in rats: an in vivo study. 3 Biotech 13:5.
Crossref
Nana Tao, Xie Xu, Yuyuan Ying, Shiyu Hu, Qingru Sun, Guiyuan Lv & Jianli Gao. (2023) Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules 28:8, pages 3539.
Crossref
Senthilkumar Preethy, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Vaddi Surya Prakash, Nobunao Ikewaki, Yasunori Ikeue, Mitsuru Nagataki, Masaru Iwasaki, Rajappa Senthilkumar & Samuel J. K. Abraham. (2022) Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis. Frontiers in Immunology 13.
Crossref
Deepak Siddavaram. (2022) Successful management of cytokine storm induced acute respiratory distress syndrome secondary to H1N1 influenza with itolizumab: A case series. IP Indian Journal of Immunology and Respiratory Medicine 7:1, pages 43-46.
Crossref
Liza Pereverzeva, Fabrice Uhel, Hessel Peters Sengers, Olaf L. Cremer, Marcus J. Schultz, Marc M. J. Bonten, Brendon P. Scicluna & Tom van der Poll. (2021) Association between delay in intensive care unit admission and the host response in patients with community-acquired pneumonia. Annals of Intensive Care 11:1.
Crossref
Juveria Usmani, Tahira Khan, Razi Ahmad & Manju Sharma. (2021) Potential role of herbal medicines as a novel approach in sepsis treatment. Biomedicine & Pharmacotherapy 144, pages 112337.
Crossref
Yatin Mehta, Subhal B Dixit, Kapil Zirpe, Randhir Sud, Palepu B Gopal, Parvaiz A Koul, Vijay K Mishra, Abdul S Ansari & Vijay S Chamle. (2021) Therapeutic Approaches in Modulating the Inflammatory and Immunological Response in Patients With Sepsis, Acute Respiratory Distress Syndrome, and Pancreatitis: An Expert Opinion Review. Cureus.
Crossref
Jian Chen & Haiming Wei. (2021) Immune Intervention in Sepsis. Frontiers in Pharmacology 12.
Crossref
Janos Szederjesi, Alexandra Lazar, Marius Petrisor, Adina Hutanu, Florin Tripon, Anca Meda Georgescu & Leonard Azamfirei. (2020) Genetic variability of ANG2-35G>C gene as a predictor factor in sepsis. Revista Romana de Medicina de Laborator 28:2, pages 175-184.
Crossref
Liise-anne Pirofski & Arturo Casadevall. (2020) Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage. Antimicrobial Agents and Chemotherapy 64:2.
Crossref
Gunnar Lachmann & Konrad Reinhart. (2020) The History of Biomarkers. Critical Care Clinics 36:1, pages 1-10.
Crossref
Wei Jiang, Xiangyou Yu, Tongwen Sun, Yanfen Chai, Ping Chang, Zhongqing Chen, Jingye Pan, Zhiyong Peng, Ruilan Wang, Xiaozhi Wang, Yuan Xu, Li Yu, Qingshan Zheng & Bin Du. (2018) ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Chengyu Li, Ping Wang, Li Zhang, Min Li, Xiang Lei, Si Liu, Zhiqiao Feng, Yongming Yao, Bai Chang, Baoshan Liu & Hongcai Shang. (2018) Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials. Journal of Ethnopharmacology 224, pages 512-521.
Crossref
Jordi Rello, Francisco Valenzuela-Sánchez, Maria Ruiz-Rodriguez & Silvia Moyano. (2017) Sepsis: A Review of Advances in Management. Advances in Therapy 34:11, pages 2393-2411.
Crossref
Yan Xu, Yan Jiang, Wentao Gai & Botao Yu. (2017) Protective role of tenuigenin on sepsis‑induced acute kidney injury in mice. Experimental and Therapeutic Medicine.
Crossref
F. Wang, J. Liu, T. Weng, K. Shen, Z. Chen, Y. Yu, Q. Huang, G. Wang, Z. Liu & S. Jin. (2017) The Inflammation Induced by Lipopolysaccharide can be Mitigated by Short-chain Fatty Acid, Butyrate, through Upregulation of IL-10 in Septic Shock. Scandinavian Journal of Immunology 85:4, pages 258-263.
Crossref
Nicole V. Tolan, Amy M. Wockenfus, Christopher D. Koch, Bridgit O. Crews, Dennis J. Dietzen & Brad S. Karon. (2017) Analytical performance of three whole blood point-of-care lactate devices compared to plasma lactate comparison methods and a flow-injection mass spectrometry method. Clinical Biochemistry 50:4-5, pages 168-173.
Crossref
Cindy Cen, Monowar Aziz & Ping Wang. 2017. Advanced Trauma and Surgery. Advanced Trauma and Surgery 211 234 .
Douglas A. Grow, John R. McCarrey & Christopher S. Navara. (2016) Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease. Stem Cell Research 17:2, pages 352-366.
Crossref
Aravind T. Reddy, Sowmya P. Lakshmi & Raju C. Reddy. (2016) PPAR ? in Bacterial Infections: A Friend or Foe? . PPAR Research 2016, pages 1-7.
Crossref
Han Wei Hou, Lidan Wu, Diana P. Amador-Munoz, Miguel Pinilla Vera, Anna Coronata, Joshua A. Englert, Bruce D. Levy, Rebecca M. Baron & Jongyoon Han. (2016) Broad spectrum immunomodulation using biomimetic blood cell margination for sepsis therapy. Lab on a Chip 16:4, pages 688-699.
Crossref
E. Plessers, A. Watteyn, H. Wyns, B. Pardon, P. De Backer & S. Croubels. (2015) Study of the immunomodulatory properties of gamithromycin and dexamethasone in a lipopolysaccharide inflammation model in calves. Research in Veterinary Science 103, pages 218-223.
Crossref
Maha Aly Fahmy, Ayman Ali Farghaly, Nagwa Hassan Ali Hassan & Kawthar Abdelaziz Elsayed Diab. (2015) Molecular and cytogenetic evaluation for potential genotoxicity of hydrocortisone. Asian Pacific Journal of Tropical Disease 5:9, pages 726-731.
Crossref
Sang Hoon HanJin Seok KimJun Hee WooSu Jin JeongJeon-Soo ShinYoung Soo AhnJune Myung Kim. (2015) The Effect of Bortezomib on Expression of Inflammatory Cytokines and Survival in a Murine Sepsis Model Induced by Cecal Ligation and Puncture. Yonsei Medical Journal 56:1, pages 112.
Crossref
Alpha A FowlerIIIIII, Aamer A Syed, Shelley Knowlson, Robin Sculthorpe, Don Farthing, Christine DeWilde, Christine A Farthing, Terri L Larus, Erika Martin, Donald F Brophy, Seema Gupta, Bernard J Fisher & Ramesh Natarajan. (2014) Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. Journal of Translational Medicine 12:1.
Crossref
E. Christaki & E.J. Giamarellos‐Bourboulis. (2014) The beginning of personalized medicine in sepsis: small steps to a bright future. Clinical Genetics 86:1, pages 56-61.
Crossref
Karolina Akinosoglou & Dimitrios Alexopoulos. (2014) Use of antiplatelet agents in sepsis: A glimpse into the future. Thrombosis Research 133:2, pages 131-138.
Crossref
Katherine Chang, Catherine Svabek, Cristina Vazquez-Guillamet, Bryan Sato, David Rasche, Strother Wilson, Paul Robbins, Nancy Ulbrandt, JoAnn Suzich, Jonathan Green, Andriani C Patera, Wade Blair, Subramaniam Krishnan & Richard Hotchkiss. (2014) Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Critical Care 18:1, pages R3.
Crossref
James N Fullerton, Alastair J O'Brien & Derek W Gilroy. (2013) Pathways mediating resolution of inflammation: when enough is too much. The Journal of Pathology 231:1, pages 8-20.
Crossref
Marcel Leist & Thomas Hartung. (2013) Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Archives of Toxicology 87:4, pages 563-567.
Crossref
Richard S Hotchkiss, Guillaume Monneret & Didier Payen. (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. The Lancet Infectious Diseases 13:3, pages 260-268.
Crossref
Xian-Di He, Yan Wang, Qiong Wu, Hua-Xue Wang, Zhen-Dong Chen, Rong-Sheng Zheng, Zi-Shu Wang, Jun-Bin Wang & Yan Yang. (2013) Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion . Evidence-Based Complementary and Alternative Medicine 2013, pages 1-11.
Crossref
Konrad Reinhart, Michael Bauer, Niels C. Riedemann & Christiane S. Hartog. (2012) New Approaches to Sepsis: Molecular Diagnostics and Biomarkers. Clinical Microbiology Reviews 25:4, pages 609-634.
Crossref
Ibtesam Abbass Hilmi. (2012) Live liver donors: Are they at a higher risk for post-operative thrombotic complications?. World Journal of Transplantation 2:1, pages 1.
Crossref
Yanna D. Rattmann, Lauro Mera de Souza, Simone M. Malquevicz-Paiva, Nessana Dartora, Guilherme Lanzi Sassaki, Philip A. J. Gorin & Marcello Iacomini. (2012) Analysis of Flavonoids from Eugenia uniflora Leaves and Its Protective Effect against Murine Sepsis . Evidence-Based Complementary and Alternative Medicine 2012, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.